Climate Change, Extreme Heat, and Health | NEJM
May 15, 2024 · The frequency, duration, and intensity of heat waves in the United States have increased in recent decades ().The annual number of heat waves is now twice that in the 1980s, and the heat wave ...
New England Journal of Medicine
The New England Journal of Medicine is a leading medical journal providing research, reviews, and commentary on clinical practice and biomedical science.
The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Systemic Light Chain Amyloidosis | New England Journal of Medicine
Jun 26, 2024 · Fibrillogenesis in immunoglobulin light chain (AL) amyloidosis is initiated from a small B-cell clone in the bone marrow that produces thermodynamically and kinetically unstable immunoglobulin ...
Effect of Early Treatment with Ivermectin among Patients with …
Mar 30, 2022 · One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites ...
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Dec 30, 2020 · Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA ...
Management of Insomnia | New England Journal of Medicine
Jul 17, 2024 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained alleviation of insomnia symptoms.
Asthma in Adults | New England Journal of Medicine
Sep 8, 2023 · The prevalence of asthma in adults in the United States is approximately 7.7%. 1 It is one of the most common chronic, noncommunicable diseases in the country and worldwide. 1,2 Among U.S. adults ...
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Dec 10, 2020 · A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 cases of Covid-19 with onset at least 7 days ...
Current Issue | New England Journal of Medicine
Explore the current issue of The New England Journal of Medicine (Vol. 391 No. 24).